Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Pediatrics
Published in: BMC Pediatrics 1/2015

Open Access 01-12-2015 | Research article

Newborn hearing screening programme in Belgium: a consensus recommendation on risk factors

Authors: Bénédicte Vos, Christelle Senterre, Raphaël Lagasse, Alain Levêque, SurdiScreen Group

Published in: BMC Pediatrics | Issue 1/2015

Login to get access

Abstract

Background

Understanding the risk factors for hearing loss is essential for designing the Belgian newborn hearing screening programme. Accordingly, they needed to be updated in accordance with current scientific knowledge. This study aimed to update the recommendations for the clinical management and follow-up of newborns with neonatal risk factors of hearing loss for the newborn screening programme in Belgium.

Methods

A literature review was performed, and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system assessment method was used to determine the level of evidence quality and strength of the recommendation for each risk factor. The state of scientific knowledge, levels of evidence quality, and graded recommendations were subsequently assessed using a three-round Delphi consensus process (two online questionnaires and one face-to-face meeting).

Results

Congenital infections (i.e., cytomegalovirus, toxoplasmosis, and syphilis), a family history of hearing loss, consanguinity in (grand)parents, malformation syndromes, and foetal alcohol syndrome presented a ‘high’ level of evidence quality as neonatal risk factors for hearing loss. Because of the sensitivity of auditory function to bilirubin toxicity, hyperbilirubinaemia was assessed at a ‘moderate’ level of evidence quality. In contrast, a very low birth weight, low Apgar score, and hospitalisation in the neonatal intensive care unit ranged from ‘very low’ to ‘low’ levels, and ototoxic drugs were evidenced as ‘very low’. Possible explanations for these ‘very low’ and ‘low’ levels include the improved management of these health conditions or treatments, and methodological weaknesses such as confounding effects, which make it difficult to conclude on individual risk factors. In the recommendation statements, the experts emphasised avoiding unidentified neonatal hearing loss and opted to include risk factors for hearing loss even in cases with weak evidence. The panel also highlighted the cumulative effect of risk factors for hearing loss.

Conclusions

We revised the recommendations for the clinical management and follow-up of newborns exhibiting neonatal risk factors for hearing loss on the basis of the aforementioned evidence-based approach and clinical experience from experts. The next step is the implementation of these findings in the Belgian screening programme.
Appendix
Available only for authorised users
Literature
1.
Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and intervention. American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998–1999. Pediatrics. 1999;103:527–30.PubMed
2.
Yoshinaga-Itano C. From screening to early identification and intervention: discovering predictors to successful outcomes for children with significant hearing loss. J Deaf Stud Deaf Educ. 2003;8:11–30.PubMed
3.
Meinzen-Derr J, Wiley S, Choo DI. Impact of early intervention on expressive and receptive language development among young children with permanent hearing loss. Am Ann Deaf. 2011;155:580–91.PubMed
4.
Vohr B, Jodoin-Krauzyk J, Tucker R, Topol D, Johnson MJ, Ahlgren M, et al. Expressive vocabulary of children with hearing loss in the first 2 years of life: impact of early intervention. J Perinatol. 2011;31:274–80.PubMed
5.
European Consensus Statement on Neonatal Hearing Screening. Finalized at the European Consensus Development Conference on Neonatal Hearing Screening. Milan, 15–16 May 1998. Acta Paediatr. 1999, 88:107–108
6.
Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007;120:898–921.
7.
US Preventive Services Task Force. Universal screening for hearing loss in newborns: US Preventive Services Task Force recommendation statement. Pediatrics. 2008;122:143–8.
8.
Beswick R, Driscoll C, Kei J. Monitoring for postnatal hearing loss using risk factors: a systematic literature review. Ear Hear. 2012;33:745–56.PubMed
9.
Wood SA, Davis AC, Sutton GJ. Effectiveness of targeted surveillance to identify moderate to profound permanent childhood hearing impairment in babies with risk factors who pass newborn screening. Int J Audiol. 2013;52:394–9.PubMed
10.
Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2000;106:798–817.
11.
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ. GRADE: What is “quality of evidence” and why is it important to clinicians? BMJ. 2008;336:995–8.PubMedPubMedCentral
12.
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.PubMed
13.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.PubMedPubMedCentral
14.
Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. GRADE: Going from evidence to recommendations. BMJ. 2008;336:1049–51.PubMedPubMedCentral
15.
Arnold GL, Van Hove J, Freedenberg D, Strauss A, Longo N, Burton B, et al. A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2009;96:85–90.PubMedPubMedCentral
16.
Foulon I, Naessens A, Foulon W, Casteels A, Gordts F. A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr. 2008;153:84–8.PubMed
17.
Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134:972–82.PubMed
18.
Kadambari S, Williams EJ, Luck S, Griffiths PD, Sharland M. Evidence based management guidelines for the detection and treatment of congenital CMV. Early Hum Dev. 2011;87:723–8.PubMed
19.
Kimberlin DW, Acosta EP, Sánchez PJ, Sood S, Agrawal V, Homans J, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–45.PubMed
20.
Kimberlin DW, Lin CY, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16–25.PubMed
21.
Oliver SE, Cloud GA, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46 Suppl 4:S22–26.PubMedPubMedCentral
22.
Andrade GM, Resende LM, Goulart EM, Siqueira AL, Vitor RW, Januario JN. Hearing loss in congenital toxoplasmosis detected by newborn screening. Braz J Otorhinolaryngol. 2008;74:21–8.PubMed
23.
24.
25.
Brown ED, Chau JK, Atashband S, Westerberg BD, Kozak FK. A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2009;73:707–11.PubMed
26.
McGee T, Wolters C, Stein L, Kraus N, Johnson D, Boyer K, et al. Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis. Otolaryngol Head Neck Surg. 1992;106:75–80.PubMed
27.
Simons EA, Reef SE, Cooper LZ, Zimmerman L, Thompson KM. Systematic Review of the Manifestations of Congenital Rubella Syndrome in Infants and Characterization of Disability-Adjusted Life Years (DALYs). Risk Anal. 2014. doi:10.​1111/​risa.​12263
28.
Austeng ME, Eskild A, Jacobsen M, Jenum PA, Whitelaw A, Engdahl B. Maternal infection with toxoplasma gondii in pregnancy and the risk of hearing loss in the offspring. Int J Audiol. 2010;49:65–8.PubMed
29.
Chau J, Atashband S, Chang E, Westerberg BD, Kozak FK. A systematic review of pediatric sensorineural hearing loss in congenital syphilis. Int J Pediatr Otorhinolaryngol. 2009;73:787–92.PubMed
30.
Gleich LL, Urbina M, Pincus RL. Asymptomatic congenital syphilis and auditory brainstem response. Int J Pediatr Otorhinolaryngol. 1994;30:11–3.PubMed
31.
McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, et al. Outcome of treatment for congenital toxoplasmosis, 1981–2004: the national collaborative Chicago-based, congenital toxoplasmosis study. Clin Infect Dis. 2006;42:1383–94.PubMed
32.
Niedzielska G, Katska E, Szymula D. Hearing defects in children born of mothers suffering from rubella in the first trimester of pregnancy. Int J Pediatr Otorhinolaryngol. 2000;54:1–5.PubMed
33.
Westerberg BD, Atashband S, Kozak FK. A systematic review of the incidence of sensorineural hearing loss in neonates exposed to Herpes simplex virus (HSV). Int J Pediatr Otorhinolaryngol. 2008;72:931–7.PubMed
34.
Bener A, Eihakeem AA, Abdulhadi K. Is there any association between consanguinity and hearing loss. Int J Pediatr Otorhinolaryngol. 2005;69:327–33.PubMed
35.
Feinmesser M, Tell L, Levi H. Consanguinity among parents of hearing-impaired children in relation to ethnic groups in the Jewish population of Jerusalem. Audiology. 1989;28:268–71.PubMed
36.
Zakzouk SM, Bafaqeeh SA. Prevalence of severe to profound sensorineural hearing loss in children having family members with hearing impairment. Ann Otol Rhinol Laryngol. 1996;105:882–6.PubMed
37.
Grundfast KM, Siparsky N, Chuong D. Genetics and molecular biology of deafness. Update. Otolaryngol Clin North Am. 2000;33:1367–94.PubMed
38.
Pickett BP, Ahlstrom K. Clinical evaluation of the hearing-impaired infant. Otolaryngol Clin North Am. 1999;32:1019–35.PubMed
39.
Tekin M, Arnos KS, Pandya A. Advances in hereditary deafness. Lancet. 2001;358:1082–90.PubMed
40.
Driscoll C, Beswick R, Doherty E, D'Silva R, Cross A. The validity of family history as a risk factor in pediatric hearing loss. Int J Pediatr Otorhinolaryngol. 2015.
41.
Khabori MA, Patton MA. Consanguinity and deafness in Omani children. Int J Audiol. 2008;47:30–3.PubMed
42.
Levi H, Tell L, Cohen T. Sensorineural hearing loss in Jewish children born in Jerusalem. Int J Pediatr Otorhinolaryngol. 2004;68:1245–50.PubMed
43.
Zakzouk S. Consanguinity and hearing impairment in developing countries: a custom to be discouraged. J Laryngol Otol. 2002;116:811–6.PubMed
44.
Dror AA, Avraham KB. Hearing loss: mechanisms revealed by genetics and cell biology. Annu Rev Genet. 2009;43:411–37.PubMed
45.
Morton CC, Nance WE. Newborn hearing screening-a silent revolution. N Engl J Med. 2006;354:2151–64.PubMed
46.
Nance WE. The genetics of deafness. Ment Retard Dev Disabil Res Rev. 2003;9:109–19.PubMed
47.
Firat Y, Sireci S, Yakinci C, Akarcay M, Karakas HM, Firat AK, et al. Isolated preauricular pits and tags: is it necessary to investigate renal abnormalities and hearing impairment? Eur Arch Otorhinolaryngol. 2008;265:1057–60.PubMed
48.
Kugelman A, Hadad B, Ben-David J, Podoshin L, Borochowitz Z, Bader D. Preauricular tags and pits in the newborn: the role of hearing tests. Acta Paediatr. 1997;86:170–2.PubMed
49.
Roth DA, Hildesheimer M, Bardenstein S, Goidel D, Reichman B, Maayan-Metzger A, et al. Preauricular skin tags and ear pits are associated with permanent hearing impairment in newborns. Pediatrics. 2008;122:e884–890.PubMed
50.
Carroll DJ, Padgitt NR, Liu M, Lander TA, Tibesar RJ, Sidman JD. The effect of cleft palate repair technique on hearing outcomes in children. Int J Pediatr Otorhinolaryngol. 2013;77:1518–22.PubMed
51.
Paliobei V, Psifidis A, Anagnostopoulos D. Hearing and speech assessment of cleft palate patients after palatal closure. Long-term results. Int J Pediatr Otorhinolaryngol. 2005;69:1373–81.PubMed
52.
Church MW, Eldis F, Blakley BW, Bawle EV. Hearing, language, speech, vestibular, and dentofacial disorders in fetal alcohol syndrome. Alcohol Clin Exp Res. 1997;21:227–37.PubMed
53.
Cone-Wesson B. Prenatal alcohol and cocaine exposure: influences on cognition, speech, language, and hearing. J Commun Disord. 2005;38:279–302.PubMed
54.
Rössig C, Wässer S, Oppermann P. Audiologic manifestations in fetal alcohol syndrome assessed by brainstem auditory-evoked potentials. Neuropediatrics. 1994;25:245–9.PubMed
55.
Church MW, Abel EL. Fetal alcohol syndrome. Hearing, speech, language, and vestibular disorders. Obstet Gynecol Clin North Am. 1998;25:85–97.PubMed
56.
Church MW, Kaltenbach JA. Hearing, speech, language, and vestibular disorders in the fetal alcohol syndrome: a literature review. Alcohol Clin Exp Res. 1997;21:495–512.PubMed
57.
Gerber SE, Epstein L, Mencher LS. Recent changes in the etiology of hearing disorders: perinatal drug exposure. J Am Acad Audiol. 1995;6:371–7.PubMed
58.
Carzoli RP, Murphy SP, Hammer-Knisely J, Houy J. Evaluation of auditory brain-stem response in full-term infants of cocaine-abusing mothers. Am J Dis Child. 1991;145:1013–6.PubMed
59.
Grimmer I, Bührer C, Aust G, Obladen M. Hearing in newborn infants of opiate-addicted mothers. Eur J Pediatr. 1999;158:653–7.PubMed
60.
Shih L, Cone-Wesson B, Reddix B. Effects of maternal cocaine abuse on the neonatal auditory system. Int J Pediatr Otorhinolaryngol. 1988;15:245–51.PubMed
61.
Tan-Laxa MA, Sison-Switala C, Rintelman W, Ostrea Jr EM. Abnormal auditory brainstem response among infants with prenatal cocaine exposure. Pediatrics. 2004;113:357–60.PubMed
62.
Ari-Even Roth D, Hildesheimer M, Maayan-Metzger A, Muchnik C, Hamburger A, Mazkeret R, et al. Low prevalence of hearing impairment among very low birthweight infants as detected by universal neonatal hearing screening. Arch Dis Child Fetal Neonatal Ed. 2006;91:F257–262.PubMed
63.
Borkoski-Barreiro SA, Falcon-González JC, Liminana-Canal JM, Ramos-Macias A. Evaluation of very low birth weight (≤1,500 g) as a risk indicator for sensorineural hearing loss. Acta Otorrinolaringol Esp. 2013;64:403–8.PubMed
64.
Doyle LW, Keir E, Kitchen WH, Ford GW, Rickards AL, Kelly EA. Audiologic assessment of extremely low birth weight infants: a preliminary report. Pediatrics. 1992;90:744–9.PubMed
65.
Martinez-Cruz CF, Garcia Alonso-Themann P, Poblano A, Ochoa-Lopez JM. Hearing loss, auditory neuropathy, and neurological co-morbidity in children with birthweight <750 g. Arch Med Res. 2012;43:457–63.PubMed
66.
Van Naarden K, Decoufle P. Relative and attributable risks for moderate to profound bilateral sensorineural hearing impairment associated with lower birth weight in children 3 to 10 years old. Pediatrics. 1999;104:905–10.PubMed
67.
Cristobal R, Oghalai JS. Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology. Arch Dis Child Fetal Neonatal Ed. 2008;93:F462–468.PubMedPubMedCentral
68.
Soleimani F, Zaheri F, Abdi F. Long-term neurodevelopmental outcomes after preterm birth. Iran Red Crescent Med J. 2014;16:e17965.PubMedPubMedCentral
69.
Borg E. Perinatal asphyxia, hypoxia, ischemia and hearing loss. An overview. Scand Audiol. 1997;26:77–91.PubMed
70.
Jiang ZD, Wilkinson AR. Neonatal auditory function and depressed Apgar score: correlation of brainstem auditory response with Apgar score. Acta Paediatr. 2006;95:1556–60.PubMed
71.
Jiang ZD, Wilkinson AR. Relationship between brainstem auditory function during the neonatal period and depressed Apgar score. J Matern Fetal Neonatal Med. 2010;23:973–9.PubMed
72.
Kvestad E, Lie KK, Eskild A, Engdahl B. Sensorineural hearing loss in children: the association with Apgar score. A registry-based study of 392,371 children in Norway. Int J Pediatr Otorhinolaryngol. 2014;78:1940–4.PubMed
73.
van Dommelen P, Mohangoo AD, Verkerk PH, van der Ploeg CP, van Straaten HL. Risk indicators for hearing loss in infants treated in different neonatal intensive care units. Acta Paediatr. 2010;99:344–9.PubMed
74.
Hille ET, van Straaten HI, Verkerk PH. Prevalence and independent risk factors for hearing loss in NICU infants. Acta Paediatr. 2007;96:1155–8.PubMed
75.
Akinpelu OV, Waissbluth S, Daniel SJ. Auditory risk of hyperbilirubinemia in term newborns: a systematic review. Int J Pediatr Otorhinolaryngol. 2013;77:898–905.PubMed
76.
Hulzebos CV, van Dommelen P, Verkerk PH, Dijk PH, Van Straaten HL. Evaluation of treatment thresholds for unconjugated hyperbilirubinemia in preterm infants: effects on serum bilirubin and on hearing loss? PLoS One. 2013;8:e62858.PubMedPubMedCentral
77.
Bhutani VK, Wong R. Bilirubin-induced neurologic dysfunction (BIND). Semin Fetal Neonatal Med. 2015;20:1.PubMed
78.
Johnson L, Bhutani VK. The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Perinatol. 2011;35:101–13.PubMed
79.
Morioka I, Iwatani S, Koda T, Iijima K, Nakamura H. Disorders of bilirubin binding to albumin and bilirubin-induced neurologic dysfunction. Semin Fetal Neonatal Med. 2014.
80.
Olds C, Oghalai JS. Audiologic impairment associated with bilirubin-induced neurologic damage. Semin Fetal Neonatal Med. 2015;20:42–6.PubMedPubMedCentral
81.
Shapiro SM, Nakamura H. Bilirubin and the auditory system. J Perinatol. 2001;21 Suppl 1:S52–55. discussion S59-62.PubMed
82.
Shapiro SM, Popelka GR. Auditory impairment in infants at risk for bilirubin-induced neurologic dysfunction. Semin Perinatol. 2011;35:162–70.PubMed
83.
Bhutani VK, Johnson-Hamerman L. The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Fetal Neonatal Med. 2015;20:6–13.PubMed
84.
Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003;29:410–21.PubMed
85.
Tan KL, Skurr BA, Yip YY. Phototherapy and the brain-stem auditory evoked response in neonatal hyperbilirubinemia. J Pediatr. 1992;120:306–8.PubMed
86.
Wong V, Chen WX, Wong KY. Short- and long-term outcome of severe neonatal nonhemolytic hyperbilirubinemia. J Child Neurol. 2006;21:309–15.PubMed
87.
Coenraad S, Goedegebure A, van Goudoever JB, Hoeve LJ. Risk factors for sensorineural hearing loss in NICU infants compared to normal hearing NICU controls. Int J Pediatr Otorhinolaryngol. 2010;74:999–1002.PubMed
88.
Kraft CT, Malhotra S, Boerst A, Thorne MC. Risk indicators for congenital and delayed-onset hearing loss. Otol Neurotol. 2014;35:1839–43.PubMed
89.
Xoinis K, Weirather Y, Mavoori H, Shaha SH, Iwamoto LM. Extremely low birth weight infants are at high risk for auditory neuropathy. J Perinatol. 2007;27:718–23.PubMed
90.
Rastogi S, Mikhael M, Filipov P, Rastogi D. Effects of ventilation on hearing loss in preterm neonates: Nasal continuous positive pressure does not increase the risk of hearing loss in ventilated neonates. Int J Pediatr Otorhinolaryngol. 2013;77:402–6.PubMed
91.
Thomas CW, Meinzen-Derr J, Hoath SB, Narendran V. Neurodevelopmental outcomes of extremely low birth weight infants ventilated with continuous positive airway pressure vs. mechanical ventilation. Indian J Pediatr. 2012;79:218–23.PubMed
92.
Pourarian S, Khademi B, Pishva N, Jamali A. Prevalence of hearing loss in newborns admitted to neonatal intensive care unit. Iran J Otorhinolaryngol. 2012;24:129–34.PubMedPubMedCentral
93.
Speleman K, Kneepkens K, Vandendriessche K, Debruyne F, Desloovere C. Prevalence of risk factors for sensorineural hearing loss in NICU newborns. B-ENT. 2012;8:1–6.PubMed
94.
de Hoog M, van Zanten BA, Hop WC, Overbosch E, Weisglas-Kuperus N, van den Anker JN. Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss. J Pediatr. 2003;142:41–6.PubMed
95.
de Hoog M, van Zanten GA, Hoeve LJ, Blom AM, van den Anker JN. A pilot case control follow-up study on hearing in children treated with tobramycin in the newborn period. Int J Pediatr Otorhinolaryngol. 2002;65:225–32.PubMed
96.
Johnson RF, Cohen AP, Guo Y, Schibler K, Greinwald JH. Genetic mutations and aminoglycoside-induced ototoxicity in neonates. Otolaryngol Head Neck Surg. 2010;142:704–7.PubMed
97.
Robertson CM, Tyebkhan JM, Peliowski A, Etches PC, Cheung PY. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr. 2006;95:214–23.PubMed
98.
Setiabudy R, Suwento R, Rundjan L, Yasin FH, Louisa M, Dwijayanti A, et al. Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates. Int J Clin Pharmacol Ther. 2013;51:401–6.PubMed
99.
Naeimi M, Maamouri G, Boskabadi H, Golparvar S, Taleh M, Esmaeeli H, et al. Assessment of aminoglycoside-induced hearing impairment in hospitalized neonates by TEOAE. Indian J Otolaryngol Head Neck Surg. 2009;61:256–61.PubMed
100.
Vella-Brincat JW, Begg EJ, Robertshawe BJ, Lynn AM, Borrie TL, Darlow BA. Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit. Neonatology. 2011;100:186–93.PubMed
101.
Estivill X, Govea N, Barcelo E, Badenas C, Romero E, Moral L, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am J Hum Genet. 1998;62:27–35.PubMedPubMedCentral
102.
Brown DR, Watchko JF, Sabo D. Neonatal sensorineural hearing loss associated with furosemide: a case–control study. Dev Med Child Neurol. 1991;33:816–23.PubMed
103.
Cheung PY, Robertson CM. Sensorineural hearing loss in survivors of neonatal extracorporeal membrane oxygenation. Pediatr Rehabil. 1997;1:127–30.PubMed
104.
Fligor BJ, Neault MW, Mullen CH, Feldman HA, Jones DT. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy. Pediatrics. 2005;115:1519–28.PubMed
105.
Murray M, Nield T, Larson-Tuttle C, Seri I, Friedlich P. Sensorineural hearing loss at 9–13 years of age in children with a history of neonatal extracorporeal membrane oxygenation. Arch Dis Child Fetal Neonatal Ed. 2011;96:F128–132.PubMed
106.
Danzer E, Kim SS. Neurodevelopmental outcome in congenital diaphragmatic hernia: Evaluation, predictors and outcome. World J Clin Pediatr. 2014;3:30–6.PubMedPubMedCentral
107.
Dennett KV, Fligor BJ, Tracy S, Wilson JM, Zurakowski D, Chen C. Sensorineural hearing loss in congenital diaphragmatic hernia survivors is associated with postnatal management and not defect size. J Pediatr Surg. 2014;49:895–9.PubMed
108.
Morando C, Midrio P, Gamba P, Filippone M, Sgro A, Orzan E. Hearing assessment in high-risk congenital diaphragmatic hernia survivors. Int J Pediatr Otorhinolaryngol. 2010;74:1176–9.PubMed
109.
Wilson MG, Riley P, Hurteau AM, Baird R, Puligandla PS. Hearing loss in congenital diaphragmatic hernia (CDH) survivors: is it as prevalent as we think? J Pediatr Surg. 2013;48:942–5.PubMed
110.
Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr. 2000, 136:611–617
111.
Konduri GG, Vohr B, Robertson C, Sokol GM, Solimano A, Singer J, et al. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J Pediatr. 2007;150:235–40. 240.e231.PubMedPubMedCentral
112.
Bao X, Wong V. Brainstem auditory-evoked potential evaluation in children with meningitis. Pediatr Neurol. 1998;19:109–12.PubMed
113.
Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317–28.PubMed
114.
Stevens JP, Eames M, Kent A, Halket S, Holt D, Harvey D. Long term outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed. 2003;88:F179–184.PubMedPubMedCentral
115.
Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J, Lui K. Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics. 2014;133:55–62.PubMed
116.
Futagi Y, Toribe Y, Ogawa K, Suzuki Y. Neurodevelopmental outcome in children with intraventricular hemorrhage. Pediatr Neurol. 2006;34:219–24.PubMed
117.
O'Shea TM, Allred EN, Kuban KC, Hirtz D, Specter B, Durfee S, et al. Intraventricular hemorrhage and developmental outcomes at 24 months of age in extremely preterm infants. J Child Neurol. 2012;27:22–9.PubMedPubMedCentral
118.
Hashemipour M, Hovsepian S, Hashemi M, Amini M, Kelishadi R, Sadeghi S. Hearing impairment in congenitally hypothyroid patients. Iran J Pediatr. 2012;22:92–6.PubMedPubMedCentral
119.
Léger J, Ecosse E, Roussey M, Lanoë JL, Larroque B. Subtle health impairment and socioeducational attainment in young adult patients with congenital hypothyroidism diagnosed by neonatal screening: a longitudinal population-based cohort study. J Clin Endocrinol Metab. 2011;96:1771–82.PubMed
120.
Lichtenberger-Geslin L, Dos Santos S, Hassani Y, Ecosse E, Van Den Abbeele T, Léger J. Factors associated with hearing impairment in patients with congenital hypothyroidism treated since the neonatal period: a national population-based study. J Clin Endocrinol Metab. 2013;98:3644–52.PubMed
121.
Barrenäs ML, Jonsson B, Tuvemo T, Hellström PA, Lundgren M. High risk of sensorineural hearing loss in men born small for gestational age with and without obesity or height catch-up growth: a prospective longitudinal register study on birth size in 245,000 Swedish conscripts. J Clin Endocrinol Metab. 2005;90:4452–6.PubMed
122.
Mancini PC, Durrant JD, Starling AL, Iório MC. Children with phenylketonuria treated early: basic audiological and electrophysiological evaluation. Ear Hear. 2013;34:236–44.PubMed
123.
Martines F, Salvago P, Bentivegna D, Bartolone A, Dispenza F, Martines E. Audiologic profile of infants at risk: experience of a Western Sicily tertiary care centre. Int J Pediatr Otorhinolaryngol. 2012;76:1285–91.PubMed
124.
Van Kerschaver E, Boudewyns AN, Declau F, Van de Heyning PH, Wuyts FL. Socio-demographic determinants of hearing impairment studied in 103,835 term babies. Eur J Public Health. 2013;23:55–60.PubMed
125.
Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64:1311–6.PubMed
126.
Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64:380–2.PubMed
127.
Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106–10.PubMedPubMedCentral
128.
Metadata
Title
Newborn hearing screening programme in Belgium: a consensus recommendation on risk factors
Authors
Bénédicte Vos
Christelle Senterre
Raphaël Lagasse
Alain Levêque
SurdiScreen Group
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2015
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-015-0479-4

Other articles of this Issue 1/2015

BMC Pediatrics 1/2015 Go to the issue

Research article

Adiposity and carotid-intima media thickness in children and adolescents: a systematic review

Research article

Development and pilot testing of Baby-Led Introduction to SolidS - a version of Baby-Led Weaning modified to address concerns about iron deficiency, growth faltering and choking

Research article

Parental anxiety related to referral of childhood heart murmur; an observational/interventional study

Research article

Resistive expressions in preschool children during peripheral vein cannulation in hospitals: a qualitative explorative observational study

Research article

Prevention of peripherally inserted central line-associated blood stream infections in very low-birth-weight infants by using a central line bundle guideline with a standard checklist: a case control study

Research article

Ten-year experience of more than 35,000 orofacial clefts in Africa